Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict)
Titel:
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict)
Auteur:
Jank, Paul Lindner, Judith Lea Lehmann, Annika Pfitzner, Berit Maria Blohmer, Jens-Uwe Horst, David Kronenwett, Ralf Denkert, Carsten Schmitt, Wolfgang Daniel